undefined
EUTM file information

018399175

RESVIVAX


February 14, 2021

Trademark Summary

The trademark application RESVIVAX was filed by Novavax, Inc., a U.S. corporation (the "Applicant"). Registration cancelled.

The application was filed in English (Italian was selected as the second language).

Cancellation Proceedings

A total of undefined cancellation proceedings were initiated against the trademark registration in 2021.The first Cancellation was filed by “БУЛ БИО – НЦЗПБ” ЕООД (BB-NCIPD Ltd.) (represented by Kostadin Manev) on April 27, 2024 and Final decision – EUTM fully cancelled.

Change of name and professional address of the trademark registration was recorded on October 13, 2021. Appointment and Replacement of representative of the trademark registration was recorded on January 3, 2022. Application for revocation or for a declaration of invalidity of the trademark registration was recorded on March 6, 2022. Appointment and Replacement of representative of the trademark registration was recorded on March 27, 2024. Decisions on applications for revocation or for a declaration of invalidity of the trademark registration was recorded on May 2, 2024.

The Cancellation with reference B 000053126 was EUTM cancelled according to Article 8(1)(b) CTMR with decision issued on January 22, 2024 by the EUIPO.


Goods And Services

  • The mark was filed in class 5 with Vaccines and vaccine adjuvants...
  • The mark was filed in class 42 with following description of goods:
    1. Pharmaceutical, biologic, and vaccine research and development
    2. Consulting services in the field of research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants
    3. Providing medical and scientific research information in the field of pharmaceuticals, biologics, and vaccines..